SAGA Transcriptional Coactivator Complex

Nara. C. Marella

Project Collaborators

Histone Modifying Complexes

MYC-driven Cancer

  • MYC proteins are master regulators of cellular programmes
  • Aberrations or upregulation of MYC-related pathways occur in the vast majority of cancers
  • MYC signalling enable tumour cells to dysregulate microenvironment & evade host immune response

SAGA Complex in MYC-driven Cancers

  • MYC members (GCN5) difficult to target with small-molecule inhibitors
  • But Acetyltransferase- and Bromo- domains in GCN5 can be targetted
  • GCN5 is part of two distinct Histone-modifying complexes, SAGA and ATAC.
  • further reading Targeting histone modifying enzymes for cancer therapy [Mustachio et. al.]

Data Independent Acquisition Workflow

Instrument

Thermo Scientific™ Orbitrap Fusion™ Lumos™ Tribrid™ Mass Spectrometer

DDA vs DIA

Mol. Omics, 2021, 17, 29-42

DDA vs DIA

Mol. Omics, 2021, 17, 29-42

Spectronaut

  • Spectral Library from RAW files of combined (Control and Treatment) conditions
  • Higher mass tolerance
  • no default imputation
  • default normalization
  • PG Quanity export

Thank you!

Any questions?